Jayne David R.W.
- SEC CIK
- 0001838242
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Directoras of Nov 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jayne David R.W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 (view filing) | May 21 | 1 day | Jayne David R.W.Director | SSale | −4.95K | $5.74 | −$28.4K | −10.0%44.4K after | |
| May 23, 2023 (view filing) | May 23 | Same day | Jayne David R.W.Director | SSale | −8.73K | $11.26 | −$98.3K | −15.0%49.3K after |